blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2800748

EP2800748 - CYCLIC AMIDE DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE AND USES THEREOF [Right-click to bookmark this link]
Former [2014/46]CYCLIC AMIDE DERIVATIVES AS INHIBITORS OF 11 - BETA - HYDROXYSTEROID DEHYDROGENASE AND USES THEREOF
[2016/39]
StatusNo opposition filed within time limit
Status updated on  02.02.2018
Database last updated on 03.09.2024
FormerThe patent has been granted
Status updated on  24.02.2017
FormerGrant of patent is intended
Status updated on  15.02.2017
FormerExamination is in progress
Status updated on  10.02.2017
Most recent event   Tooltip17.07.2020Lapse of the patent in a contracting state
New state(s): AL		published on 19.08.2020  [2020/34]
Applicant(s)For all designated states
Connexios Life Sciences Pvt. Ltd.
Prestige South End
No. 28/1-91, 3rd Floor
South End Road
Opp. Surana College, Basavanagudi
Bengaluru, Karnataka 560004 / IN
[2016/29]
Former [2014/46]For all designated states
Connexios Life Sciences Pvt. Ltd.
No.49 Shilpa Vidya
First Main Road
J P Nagar 3rd Phase
Bangalore 560 078 / IN
Inventor(s)01 / RAO, Jagannath Madanahalli Ranganath
No.49 Shilpa Vidya
First Main Road
J P Nagar 3rd Phase
Bangalore 560078 / IN
02 / VENKATESHAM, Uppala
No.49 Shilpa Vidya
First Main Road
J P Nagar 3rd Phase
Bangalore 560078 / IN
03 / GEORGE, Jenson
No.49 Shilpa Vidya
First Main Road
J P Nagar 3rd Phase
Bangalore 560078 / IN
04 / FERNAND, George
No.49 Shilpa Vidya
First Main Road
J P Nagar 3rd Phase
Bangalore 560078 / IN
05 / DOPPALAPUDI, Sivanageswara Rao
No.49 Shilpa Vidya
First Main Road
J P Nagar 3rd Phase
Bangalore 560078 / IN
06 / MADHAVAN, G R
No.49 Shilpa Vidya
First Main Road
J P Nagar 3rd Phase
Bangalore 560078 / IN
07 / ARUMUGAM, Nagarajan
No.49 Shilpa Vidya
First Main Road
J P Nagar 3rd Phase
Bangalore 560078 / IN
08 / ANSARI, Mohammed
No.49 Shilpa Vidya
First Main Road
J P Nagar 3rd Phase
Bangalore 560078 / IN
09 / MURUGAVEL, K
No.49 Shilpa Vidya
First Main Road
J P Nagar 3rd Phase
Bangalore 560078 / IN
10 / PRADEEP, Jidugu
No.49 Shilpa Vidya
First Main Road
J P Nagar 3rd Phase
Bangalore 560078 / IN
11 / ALLAVUDDEEN, Sulthan
No.49 Shilpa Vidya
First Main Road
J P Nagar 3rd Phase
Bangalore 560078 / IN
12 / VIJAYARAMALINGAM, K
No.49 Shilpa Vidya
First Main Road
J P Nagar 3rd Phase
Bangalore 560078 / IN
13 / PRASAD, Hampelingaiah Shiva
No.49 Shilpa Vidya
First Main Road
J P Nagar 3rd Phase
Bangalore 560078 / IN
14 / RAJ, Augustine Michael
No.49 Shilpa Vidya
First Main Road
J P Nagar 3rd Phase
Bangalore 560078 / IN
15 / GNANAVEL, S
No.49 Shilpa Vidya
First Main Road
J P Nagar 3rd Phase
Bangalore 560078 / IN
16 / KOTTAMALAI, Ramamoorthy
No.49 Shilpa Vidya
First Main Road
J P Nagar 3rd Phase
Bangalore 560078 / IN
17 / BABU, Naresh M P S
No.49 Shilpa Vidya
First Main Road
J P Nagar 3rd Phase
Bangalore 560078 / IN
18 / KENCHEGOWDA, Bommegowda Yadaganahalli
No.49 Shilpa Vidya
First Main Road
J P Nagar 3rd Phase
Bangalore 560078 / IN
 [2014/46]
Representative(s)Games, Robert Harland
Albright IP Limited
County House
Bayshill Road
Cheltenham, Glos. GL50 3BA / GB
[2017/13]
Former [2014/46]Hally, Anna-Louise
FRKelly
27 Clyde Road
Dublin 4 / IE
Application number, filing date12846788.321.12.2012
[2017/13]
WO2012IN00841
Priority number, dateIN2011CHE452722.12.2011         Original published format: IN 4527CH2011
[2017/16]
Former [2014/46]IN2011CHE452722.12.2011
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013128465
Date:06.09.2013
Language:EN
[2013/36]
Type: A1 Application with search report 
No.:EP2800748
Date:12.11.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 06.09.2013 takes the place of the publication of the European patent application.
[2014/46]
Type: B1 Patent specification 
No.:EP2800748
Date:29.03.2017
Language:EN
[2017/13]
Search report(s)International search report - published on:EP06.09.2013
ClassificationIPC:C07D401/12, C07D401/06, C07D471/04, C07D413/06, C07D417/12, C07D403/06, C07D405/06, A61K31/437, A61K31/4725, A61P3/10
[2014/46]
CPC:
C07D471/04 (EP,CN,RU,US); C07D401/12 (EP,CN,RU,US); C07D401/06 (EP,CN,RU,US);
A61K31/4709 (RU); A61K31/4725 (RU); A61P13/12 (EP);
A61P19/02 (EP); A61P19/10 (EP); A61P25/18 (EP);
A61P25/24 (EP); A61P25/28 (EP); A61P27/02 (EP);
A61P27/06 (EP); A61P29/00 (EP); A61P3/04 (EP);
A61P3/06 (EP); A61P3/10 (EP,RU); A61P31/12 (EP);
A61P43/00 (EP); A61P5/50 (EP); A61P9/10 (EP);
A61P9/12 (EP); C07D209/18 (CN); C07D209/44 (EP,CN,US);
C07D401/08 (CN); C07D403/06 (EP,CN,RU,US); C07D405/06 (EP,CN,RU,US);
C07D405/14 (EP,CN,US); C07D409/14 (EP,CN,US); C07D413/06 (EP,CN,RU,US);
C07D413/14 (CN); C07D417/06 (EP,CN,US); C07D417/12 (EP,CN,RU,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/46]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:ZYCLISCHE AMIDDERIVATIVE ALS INHIBITOREN DER 11-BETA-HYDROXYSTEROID DEHYDROGENASE AND IHRE VERWENDUNG[2016/39]
English:CYCLIC AMIDE DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE AND USES THEREOF[2016/39]
French:DERIVES DES AMIDES CYCLIQUES COMME INHIBTEURS DE LA DEHYDROGENASE DE 11-BETA-HYDROXYSTEROIDE ET LEURS UTILISATION[2016/39]
Former [2014/46]CYCLISCHE AMIDDERIVATE ALS INHIBITOREN VON 11 BETA-HYDROXYSTEROID-DEHYDROGENASE UND VERWENDUNGEN DAVON
Former [2014/46]CYCLIC AMIDE DERIVATIVES AS INHIBITORS OF 11 - BETA - HYDROXYSTEROID DEHYDROGENASE AND USES THEREOF
Former [2014/46]DÉRIVÉS D'AMIDE CYCLIQUES À UTILISER EN TANT QU'INHIBITEURS DE 11-BÊTA-HYDROXYSTÉROÏDE DÉSHYDROGÉNASE ET UTILISATIONS DE CEUX-CI
Entry into regional phase22.07.2014National basic fee paid 
22.07.2014Designation fee(s) paid 
22.07.2014Examination fee paid 
Examination procedure19.09.2013Request for preliminary examination filed
International Preliminary Examining Authority: EP
22.07.2014Examination requested  [2014/46]
23.03.2015Amendment by applicant (claims and/or description)
17.11.2015Despatch of a communication from the examining division (Time limit: M06)
18.05.2016Reply to a communication from the examining division
12.10.2016Communication of intention to grant the patent
08.02.2017Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
08.02.2017Fee for grant paid
08.02.2017Fee for publishing/printing paid
15.02.2017Information about intention to grant a patent
15.02.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  17.11.2015
Opposition(s)03.01.2018No opposition filed within time limit [2018/10]
Fees paidRenewal fee
26.06.2015Renewal fee patent year 03
21.12.2015Renewal fee patent year 04
20.12.2016Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.12.201403   M06   Fee paid on   26.06.2015
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU21.12.2012
AL29.03.2017
AT29.03.2017
CY29.03.2017
CZ29.03.2017
EE29.03.2017
FI29.03.2017
HR29.03.2017
LT29.03.2017
LV29.03.2017
MC29.03.2017
MK29.03.2017
PL29.03.2017
RO29.03.2017
RS29.03.2017
SE29.03.2017
SI29.03.2017
SK29.03.2017
SM29.03.2017
TR29.03.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
PT31.07.2017
LU21.12.2017
MT21.12.2017
[2020/34]
Former [2020/15]HU21.12.2012
AT29.03.2017
CY29.03.2017
CZ29.03.2017
EE29.03.2017
FI29.03.2017
HR29.03.2017
LT29.03.2017
LV29.03.2017
MC29.03.2017
MK29.03.2017
PL29.03.2017
RO29.03.2017
RS29.03.2017
SE29.03.2017
SI29.03.2017
SK29.03.2017
SM29.03.2017
TR29.03.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
PT31.07.2017
LU21.12.2017
MT21.12.2017
Former [2019/51]HU21.12.2012
AT29.03.2017
CY29.03.2017
CZ29.03.2017
EE29.03.2017
FI29.03.2017
HR29.03.2017
LT29.03.2017
LV29.03.2017
MC29.03.2017
MK29.03.2017
PL29.03.2017
RO29.03.2017
RS29.03.2017
SE29.03.2017
SI29.03.2017
SK29.03.2017
SM29.03.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
PT31.07.2017
LU21.12.2017
MT21.12.2017
Former [2019/47]HU21.12.2012
AT29.03.2017
CY29.03.2017
CZ29.03.2017
EE29.03.2017
FI29.03.2017
HR29.03.2017
LT29.03.2017
LV29.03.2017
MC29.03.2017
PL29.03.2017
RO29.03.2017
RS29.03.2017
SE29.03.2017
SI29.03.2017
SK29.03.2017
SM29.03.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
PT31.07.2017
LU21.12.2017
MT21.12.2017
Former [2019/31]HU21.12.2012
AT29.03.2017
CZ29.03.2017
EE29.03.2017
FI29.03.2017
HR29.03.2017
LT29.03.2017
LV29.03.2017
MC29.03.2017
PL29.03.2017
RO29.03.2017
RS29.03.2017
SE29.03.2017
SI29.03.2017
SK29.03.2017
SM29.03.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
PT31.07.2017
LU21.12.2017
MT21.12.2017
Former [2019/30]AT29.03.2017
CZ29.03.2017
EE29.03.2017
FI29.03.2017
HR29.03.2017
LT29.03.2017
LV29.03.2017
MC29.03.2017
PL29.03.2017
RO29.03.2017
RS29.03.2017
SE29.03.2017
SI29.03.2017
SK29.03.2017
SM29.03.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
PT31.07.2017
LU21.12.2017
MT21.12.2017
Former [2018/43]AT29.03.2017
CZ29.03.2017
EE29.03.2017
FI29.03.2017
HR29.03.2017
LT29.03.2017
LV29.03.2017
PL29.03.2017
RO29.03.2017
RS29.03.2017
SE29.03.2017
SI29.03.2017
SK29.03.2017
SM29.03.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
PT31.07.2017
LU21.12.2017
MT21.12.2017
Former [2018/25]AT29.03.2017
CZ29.03.2017
EE29.03.2017
FI29.03.2017
HR29.03.2017
LT29.03.2017
LV29.03.2017
PL29.03.2017
RO29.03.2017
RS29.03.2017
SE29.03.2017
SI29.03.2017
SK29.03.2017
SM29.03.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
PT31.07.2017
Former [2017/51]AT29.03.2017
CZ29.03.2017
EE29.03.2017
FI29.03.2017
HR29.03.2017
LT29.03.2017
LV29.03.2017
PL29.03.2017
RO29.03.2017
RS29.03.2017
SE29.03.2017
SK29.03.2017
SM29.03.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
PT31.07.2017
Former [2017/50]AT29.03.2017
CZ29.03.2017
EE29.03.2017
FI29.03.2017
HR29.03.2017
LT29.03.2017
LV29.03.2017
PL29.03.2017
RO29.03.2017
RS29.03.2017
SE29.03.2017
SK29.03.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
Former [2017/49]AT29.03.2017
CZ29.03.2017
EE29.03.2017
FI29.03.2017
HR29.03.2017
LT29.03.2017
LV29.03.2017
RO29.03.2017
RS29.03.2017
SE29.03.2017
SK29.03.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
IS29.07.2017
Former [2017/48]CZ29.03.2017
FI29.03.2017
HR29.03.2017
LT29.03.2017
LV29.03.2017
RS29.03.2017
SE29.03.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
Former [2017/41]FI29.03.2017
HR29.03.2017
LT29.03.2017
LV29.03.2017
RS29.03.2017
SE29.03.2017
BG29.06.2017
NO29.06.2017
GR30.06.2017
Cited inInternational search[X]DE2903966  (BAYER AG);
 [X]US5631279  (CRESPO ANDRE [FR], et al);
 [XI]WO9952876  (SANOFI SYNTHELABO [FR], et al);
 [XI]EP1340749  (TAKEDA CHEMICAL INDUSTRIES LTD [JP]);
 [X]WO2005073199  (AVENTIS PHARMA GMBH [DE], et al);
 [XI]WO2005075471  (BIOVITRUM AB [SE], et al);
 [X]WO2006012504  (DAIAMED INC [US], et al);
 [X]WO2009126675  (BOEHRINGER INGELHEIM INT [DE], et al);
 [XI]WO2010139827  (SALVAT LAB SA [ES], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.